Garrison Point Advisors LLC Grows Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Garrison Point Advisors LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.5% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 10,442 shares of the financial services provider’s stock after acquiring an additional 158 shares during the quarter. iShares Biotechnology ETF accounts for 0.9% of Garrison Point Advisors LLC’s portfolio, making the stock its 29th largest position. Garrison Point Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,433,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in IBB. Future Financial Wealth Managment LLC bought a new stake in iShares Biotechnology ETF during the first quarter valued at about $27,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $31,000. Pacifica Partners Inc. increased its holdings in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares in the last quarter. Crewe Advisors LLC increased its holdings in iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 78 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $37,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.3 %

IBB opened at $144.92 on Wednesday. The company has a 50 day simple moving average of $144.45 and a two-hundred day simple moving average of $138.13. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.